Lv1
22 积分 2023-10-20 加入
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
18天前
已完结
BCMA-targeted therapies in multiple myeloma: advances, challenges and future prospects
24天前
已完结
Management of adults with T-cell lymphoblastic leukemia
1个月前
已完结
Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring
1个月前
已完结
Hyper‐CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome‐Negative B‐Cell Acute Lymphoblastic Leukemia
1个月前
已完结
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
1个月前
已完结
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options
1个月前
已完结
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis
1个月前
已完结
Novel Treatment Options for Multiple Myeloma
1个月前
已完结
Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis
1个月前
已完结
皖公网安备34019202002308
